TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422G957. A total of 1 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $530 | +3212.5% | 59,300 | +5290.9% | 0.00% | – |
| Q2 2023 | $16 | -95.2% | 1,100 | -92.5% | 0.00% | – |
| Q1 2023 | $330 | +16400.0% | 14,700 | +14600.0% | 0.00% | – |
| Q4 2022 | $2 | -100.0% | 100 | -50.0% | 0.00% | – |
| Q2 2022 | $4,000 | -99.3% | 200 | -99.1% | 0.00% | -100.0% |
| Q1 2022 | $559,000 | -30.1% | 21,700 | -15.9% | 0.00% | 0.0% |
| Q4 2021 | $800,000 | +39.1% | 25,800 | -30.1% | 0.00% | 0.0% |
| Q3 2021 | $575,000 | +8.1% | 36,900 | +1.1% | 0.00% | 0.0% |
| Q2 2021 | $532,000 | -34.8% | 36,500 | +11062.1% | 0.00% | 0.0% |
| Q1 2021 | $816,000 | +5.2% | 327 | +14.7% | 0.00% | 0.0% |
| Q4 2020 | $776,000 | – | 285 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |